Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa

Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa

Abstract Background There is emerging evidence that stimulants warrant further investigation as a treatment for bulimia nervosa (BN) including a recent open-label feasibility trial examining the use of lisdexamfetamine dimestylate (LDX) for BN. The current report presents the secondary outcomes and...

Full description

Bibliographic Details
Main Authors: Laura Dixon, Sara Bartel, Victoria Brown, Sarrah I. Ali, Susan Gamberg, Andrea Murphy, Katherine L. Brewer, Susan L. McElroy, Allan Kaplan, Abraham Nunes, Aaron R. Keshen
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Journal of Eating Disorders
Subjects:
Bulimia nervosa
Lisdexamfetamine dimesylate
Qualitative research
Stimulant
Pharmacotherapy
Online Access:https://doi.org/10.1186/s40337-023-00796-x

Internet

https://doi.org/10.1186/s40337-023-00796-x

Similar Items